Omar Bakr, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bakr’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A152366 · Current
Licensed to practise in California · since 2017 · expires 2027-10-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,387
Medicare paid this office $3,387 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 65 · Health risk score 2.06. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
The office billed $20,352, Medicare allowed $5,398 and paid $3,387; for 21 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 21 | 65 | 2.06 | $20,352 | $3,387 |
| 2023 | 17 | 22 | 64 | 2.43 | $15,271 | $3,072 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$69,953
Pharmacies billed $69,953 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 481) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
435 generic and 46 brand-name prescriptions · $69,953 in drug cost · 24 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 12 | $34,115 | $2,843 |
| Mesalamine | 16 | $6,670 | $417 |
| Gavilyte-C | 221 | $4,996 | $23 |
| Omeprazole | 64 | $540 | $8 |
| Peg-3350 and Electrolytes | 20 | $537 | $27 |
See all 10 drugs
| Creon | 12 | $34,115 | $2,843 |
| Mesalamine | 16 | $6,670 | $417 |
| Gavilyte-C | 221 | $4,996 | $23 |
| Omeprazole | 64 | $540 | $8 |
| Peg-3350 and Electrolytes | 20 | $537 | $27 |
| Cholestyramine | 11 | $504 | $46 |
| Lactulose | 13 | $382 | $29 |
| Pantoprazole | 27 | $339 | $13 |
| Esomeprazole Magnesium | 12 | $325 | $27 |
| Carvedilol | 22 | $171 | $8 |
Year by year
| 2024 | 481 | 292 | 0% (0) | 10% | $69,953 |
| 2023 | 368 | 260 | 0% (0) | 13% | $26,997 |
| 2022 | 150 | 100 | 0% (0) | 23% | $16,891 |
| 2021 | 84 | 22 | 0% (0) | 30% | $67,635 |
| 2020 | 97 | 25 | 0% (0) | None | $25,374 |
| 2019 | 70 | 25 | None | None | $6,987 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Gavilyte-C | 185 | $3,909 | $21 |
| Peg-3350 and Electrolytes | 38 | $988 | $26 |
| Pantoprazole | 19 | $495 | $26 |
| Omeprazole | 36 | $260 | $7 |
| Carvedilol | 16 | $117 | $7 |
2022: 3 drugs
| Gavilyte-C | 63 | $1,248 | $20 |
| Omeprazole | 14 | $133 | $10 |
| Humira | 13 | $131 | $10 |
2021: 2 drugs
| Vemlidy | 18 | $22,648 | $1,258 |
| Entecavir | 29 | $1,899 | $65 |
2020: 2 drugs
| Entecavir | 35 | $7,370 | $211 |
| Mercaptopurine | 11 | $177 | $16 |
Money from drug and device companies
$125 in 2022
| 2022 | 1 | 1 | None | $125 |
| 2021 | 1 | 1 | None | $122 |
| 2020 | 1 | 1 | None | $128 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Seagen | Adcetris | $125 | 1 payment
|
See the published payment
| Seagen | Meals · 2022-03-31 | Adcetris | $125 |
See earlier years (2021, 2020)
2021: $122
| Pharmacyclics LLC an AbbVie | Imbruvica | $122 | 1 payment
|
2020: $128
| Genentech USA | None | $128 | 1 payment
|
Professional record
- NPI
- 1275995953
- Licence
- CA A152366California A152366: Current · expires 2027-10-31
- Trained
- University of California, San Francisco School of Medicine, 2016
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 260 International Cir, San Jose, CA, 95119
- NPI first listed
- 2016-03-22
- NPI last updated
- 2022-08-01
- NPI record certified
- 2022-08-01
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.